In March, the WHO released three new target product profiles for urgently needed antibiotics designed to address key drug-resistant bacteria. At ESCMID Global 2026 we caught up with Valeria Gigante…

Here you can read up on the AMR Science-Policy Forum that took place at ESCMID Global 2026 and watch the recording of the keynote lecture. Thanks to AMR Solutions's John Rex for the insightful review.

A coalition of over 20 international partners announced the Global One Health Diagnostics Access Compact (GO-Dx) to serve as a catalyst to advance diagnostics access and improving response against AMR

Early registration is now available for the second edition of the Global AMR Innovators' Conference (GAMRIC) taking place 22-24 September 2026 in Lisbon, Portugal.

Read the report from this joint AMR symposium exploring challenges that prevent diagnostics from being effective against AMR and how to overcome these barriers.

The AMR Action Subcommittee alongside the ESCMID Study Group on Artificial Intelligence and Digitalisation (ESGAID) summarises current advances and challenges in applying AI for tackling AMR.

Michael Sharland from the ESCMID AMR Action Subcommittee delivered a comprehensive webinar on the Independent Panel on Evidence for Action on Antimicrobial Resistance (IPEA).

The AMR Action Subcommittee discuss the importance of metrics as a key for global action. Holger Rode focuses on the need to reframe how we talk about AMR as a biological phenomenon that impacts…

This policy brief was produced by the Global Strategy Lab and ESCMID. It discusses the key decision included in the IPEA founding documents and proposes an approach and topics for scientific…

If you weren't able to attend the Global AMR Innovators Conference (GAMRIC), or you want to catch up on sessions you missed, a comprehensive round-up is now live.

The WHO released three reports providing a comprehensive overview of the current state of antibacterial drug development, the landscape of diagnostic tools for priority bacterial pathogens, and the…

ESCMID is proud to collaborate on the following contribution to the zero draft of the founding document for the Independent Panel on Evidence for Action Against AMR (IPEA).

In the second edition of the Global Health Resilience campaign, the AMR Action Subcommittee focused on the need to bolster overall health systems and create systemic change instead of just funding…

At ESCMID Global 2025 ESCMID and GLG hosted the third AMR Science-Policy Forum to discuss the outcomes of the 2024 UNGA-AMR High-level meeting.

The AMR Action Subcommittee took part in the Mediaplanet Global Health Resilience campaign bringing the topic of AMR to light. Read the full article covering the need for collaboration.

The ESCMID AMR Action Subcommittee took part in a global health resilience campaign focusing on AMR and bringing science and policy together. Read the full article here.

ESCMID members comments on the first-ever report from WHO addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases.

Read the new commentary on key takeaways from the AMR Action Subcommittee and TAE now available in CMI Comms